Spravato (esketamine) is prescribed for adults to treat: major depressive disorder (MDD), also called depression, with suicidal thoughts or actions treatment-resistant depression For MDD ...

New Directions Mental Health's Greensburg clinic now offers SPRAVATO®, an FDA-approved nasal spray for fast relief from treatment-resistant depression. GREENSBURG, PA, UNITED STATES, March 26 ...

Elon Musk discussed his use of ketamine for depression during an interview, claiming it helps him combat negative mental ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

So SPRAVATO is indicated for treatment resistant depression. It is esketamine. It's a single enantiomer of ketamine. It's an intranasally administered compound. It was approved in 2019 for ...

In 2019, esketamine (Spravato), derived from ketamine, was approved by the FDA as a nasal spray for treatment-resistant depression. While ketamine therapy has shown promising results, its use ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

Stifel writes, “commercial success of Spravato offers major validation that the intermittent psychedelic treatment model for depression is scalable.” Stifel has initiated with a Buy rating and ...

Tesla boss Elon Musk seems to be on a mission to conquer the world, and even Mars. But his odd-hour rants, alleged Nazi ...